NCT00221312View on ClinicalTrials.gov

Fosamax Bone Loss Study: Alendronate to Prevent Bone Loss

CompletedOBSERVATIONAL
Enrollment

48

Participants

Timeline

Start Date

May 31, 2002

Study Completion Date

July 31, 2007

Conditions
Perimenopausal Bone Loss
Interventions
DRUG

Fosamax

Trial Locations (1)

94143

University of California, San Francisco, San Francisco

All Listed Sponsors
lead

University of California, San Francisco

OTHER

NCT00221312 - Fosamax Bone Loss Study: Alendronate to Prevent Bone Loss | Biotech Hunter | Biotech Hunter